Mereo BioPharma Group plc SEC filings MREO

Mereo BioPharma Group plc has 439 filings in SEC EDGAR's recent list, going back to Dec 1, 2017. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 19, 2026 (listing notice). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 9, 2026 Dec 31, 2025
10-K Annual report Mar 19, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 8, 2025 Dec 31, 2024
10-K Annual report Mar 26, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 24, 2024 Dec 31, 2023
10-K Annual report Mar 27, 2024 Dec 31, 2023
20-F Annual report (foreign issuer) Mar 28, 2023 Dec 31, 2022
20-F Annual report (foreign issuer) Mar 31, 2022 Dec 31, 2021
20-F Annual report (foreign issuer) Mar 31, 2021 Dec 31, 2020
20-F Annual report (foreign issuer) Jun 15, 2020 Dec 31, 2019
20-F/A Amended annual report (foreign issuer) May 29, 2019 Dec 31, 2018
20-F Annual report (foreign issuer) Apr 29, 2019 Dec 31, 2018

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
MREO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
United Kingdom
Headquarters
London
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1719714

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.